GERMANY: MILTEFOSIN AGAINST LEISHMANIASIS

Article Abstract:

Researchers of Asta Medica found out that the active substance miltefosin is an effective treatment for visceral leishmaniasis, one of the most widespread tropical diseases. Tests in the Indian region of Bihar have shown that a drug based on miltefosin has only minor side effects. After 14 days, 21 out of 30 patients were freed from the protozoans. According to a spokesman of Asta Medica, the drug is to receive clearance for India and other countries in the "foreseeable future." The World Health Organisation will take over substantial parts of the costs for a clinical test programme. In total, about 350mn of people are threatened by the leishmaniasis. More than 12mn people are already suffering from the disease, which may be fatal if untreated. Since leishmaniasis also affects dogs, foxes and wild rodents in Europe, the drug might also be used in veterinary medicine.

Comment:

Active substance miltefosin is an effective treatment for visceral leishmaniasis

Research & development outlays, Pharmaceutical Preparation Manufacturing, Antiinfective Preparations, Antibacterial & Antiseptic Preps, Anti-infective agents, Asta Medica AG

---

SWITZERLAND/GERMANY: NEW WAYS IN DRUG PACKAGING

Article Abstract:

The Swiss Grabs-based labels and labelling technology company Pago AG offers pharmaceutical packaging that combines the label and the instructions for the patient. The label with the instructions is folded several times around the product, making folding boxes redundant. The packaging allows a variety of designs, and the packing process is made more efficient, as the label is adhered during filling of the bottle. In Germany, Astra-Zeneca of Wedel uses a blister packaging that combines a cardboard piece and a brochure. The packaging can be re-closed by folding the brochure and the blister. Thus the patient's instructions remain in the packaging.

Product information, Switzerland, Manufacturing processes, Product introduction, Marketing, Paperboard Containers, Paperboard Container Manufacturing, Flat Glass, Flat Glass Manufacturing, Misc. Converted Paper Products, Paperboard Containers and Boxes, Paper Bags, Uncoated Paper and Multiwall Bag Manufacturing, Pago AG, Paper products industry, Astra Zeneca

---

GERMANY: MERCK UPS PHARMACEUTICAL PRODUCTION

Article Abstract:

German Darmstadt-based Merck KGaA has completed a DM 70mn investment in the modernisation and expansion of tablet production and packaging in Darmstadt. While in year 2000 the plant will produce about 3bn tablets (up 30% from three years ago), the capacity of the plant can be expanded to 8bn-10bn units per year. The investment allowed Merck to extend the range of products made at the plant. The product range comprises 90 different preparations.

New capacity, new plant construction, Merck and Company Inc., Merck KGAA, MERCK UPS PHARMACEUTICAL

Similar abstracts:

• Abstracts: GERMANY: PHARMACEUTICAL INVESTMENT BY BRAUN. SWITZERLAND/US: WYETH-AYERST DRUG TO ARES-SERONO. US: NOVARTIS INVESTING IN EAST HANOVER
• Abstracts: GERMANY: MICROM LABORGERATE TO SYBRON. GERMANY: AVENTIS CROPSCIENCE UPS PRODUCTION. US: ENNIS-AGRI-TECH TO GERMAN VTG-LEHNKERING
• Abstracts: GERMANY: REORGANISATION AT WELLA. Germany: Wella forecast for markets, profits. GERMANY: COSMETIC, DETERGENT FIRMS CONFIDENT
• Abstracts: Schizophrenia, the dopamine hypothesis and alpha(sub)2-adrenoceptor antagonists. Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.